AI Startup Isomorphic Labs Preps Human Trials for AI-Designed Drugs
Summary
AI startup Isomorphic Labs, spun out of DeepMind, prepares for human trials of drugs designed by cutting-edge AI paired with pharma experts, aiming for 100% conviction drugs will work before trials, promising faster, cheaper and more accurate medicine design.
Key Points
- Isomorphic Labs, spun out of DeepMind, is preparing for human trials of AI-designed drugs.
- The company pairs cutting-edge AI with pharma veterans to design medicines faster, cheaper and more accurately.
- Isomorphic aims to harness AI like AlphaFold to achieve 100% conviction that drugs will work before trials.